ArticleSensors (Basel, Switzerland)2025
Framework Using Multicriteria Analysis for Evaluating the Risk of Musculoskeletal Disorders.
Article in Sensors (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study includes musculoskeletal disorder (MSD) risk evaluation based on the IMU sensor data gathered from patient-lifting movement performed by healthcare specialists. This is a continuation of previous research focusing on a novel multicriteria statistical model integrating experimental and large-scale statistical datasets. The proposed model estimates MSD probabilities over 5, 10, and 15 years for the neck (0.537 ± 0.156), shoulder (0.449 ± 0.084), and elbows (0.277 ± 0.221). The model enables individual risk profiling, influenced by dynamic parameters that can reduce the long-term risk by up to 70.49%. The model is in its early development stages, i.e., it is the proof of concept that offers a new approach to assessing MSD risk at work using motion tracking data in combination with statistics. Further studies with larger sample sizes and validated criterion weights are needed to refine and validate this approach.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.